100% accuracy
of data
of data
24/7 scientific
support
support
0% tolerance in
quality of product
quality of product
Stock Locations
- New Jersey, USA
- Czech Republic, EU
- Mumbai, India
* Stock subject to availability.
Documentation
Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.
1789703-37-2Vildagliptin Imine Impurity
● In Stock
| Catalogue No.: | VE006421 |
|---|---|
| CAS No.: | 1789703-37-2 |
| Mol. Formula: | C17H25N3O2 |
| Mol. Weight: | 303.4 |
Additional information on CAS 1789703-37-2
Parent drug
VildagliptinIUPAC Name
2-((1r,3s,5R,7S)-3-hydroxyadamantan-1-yl)-1-iminohexahydropyrrolo[1,2-a]pyrazin-4(1H)-onePharmacopoeial Synonyms
N/AOther Synonyms
Vildagliptin Cyclo Imidamide; Vildagliptin Impurity A; 2-(3-Hydroxyadamantan-1-yl)-1-iminohexahydropyrrolo[1,2-a]pyrazin-4(1H)-one; Vildagliptin Mono Keto ImpuritySmile
O=C1CN([C@]23C[C@]4(O)C[C@](C3)([H])C[C@@](C4)([H])C2)C(C5N1CCC5)=NInChI
InChI=1S/C17H25N3O2/c18-15-13-2-1-3-19(13)14(21)9-20(15)16-5-11-4-12(6-16)8-17(22,7-11)10-16/h11-13,18,22H,1-10H2/t11-,12+,13?,16+,17+Description
Vildagliptin Imine Impurity is a well-characterized reference material that meets stringent regulatory standards set by USP, EMA, JP, and BP. It plays a key role in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial production of Vildagliptin. It is an orally-active antihyperglycemic agent that manages type II diabetes mellitus by inhibiting the DD4 enzyme.
References
By K.M. Prasanna Kumar, U. Phadke, H. Brath, A. Gawai, P.M. Paldánius, C. Mathieu Container: Primary Care Diabetes Year: 2016 Volume: 10 Issue: 6 DOI: 10.1016/j.pcd.2016.06.001 URL: https://www.sciencedirect.com/science/article/pii/S1751991816300432Request a Quote
"*" indicates required fields
Other products related to Vildagliptin impurities
Impurity structure
Parent Drug Name
CAS No.
Name of Impurity
Catalog No.
